SYDRA

Website
Founded
2024
2024
SYDRA is an AI-driven biotechnology startup developing novel small molecules designed to extend healthy lifespan and delay age-related decline. Our proprietary platform combines generative molecular models, longevity-focused prediction algorithms, cheminformatics, and automated phenotypic screening in C. elegans to generate, prioritize, and experimentally validate previously unexplored geroprotective compounds. By integrating computational drug design with rapid in vivo testing, SYDRA aims to reduce the time, cost, and failure rate of early-stage longevity drug discovery and advance the most promising candidates toward mammalian validation and therapeutic development.